The Asia-Pacific Proton Pump Inhibitors Market has been experiencing significant growth due to the rising prevalence of gastrointestinal disorders and an increasing geriatric population. Proton pump inhibitors (PPIs) are a class of medications that reduce stomach acid production, effectively treating conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian